Safety prophylactic efficacy low-dose rimantadine adults influenza epidemic placebo-controlled double-blind study safety prophylactic efficacy low dose mg rimantadine hydrochloride influenza adults sites onset influenza season volunteers ages years rimantadine placebo daily Subjects adverse effects evidence influenza virus infection weekly weeks rimantadine recipients placebo control recipients mild adverse symptoms gastrointestinal central nervous system placebo low-dose rimantadine effective prevention influenza virus infection versus participants influenza illness versus participants Influenza virus nasopharynxes placebo recipients findings low-dose rimantadine effective prevention influenza illness healthy adults 